Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor
Year: 2014
Type: article
Study design: Case Report
Source: Journal of Clinical Apheresis
DOI: 10.1002/jca.21348
Institution: University of Arkansas for Medical Sciences
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1740651174